Amylyx Pharmaceuticals, Inc. (AMLX) has a market capitalization of $1.41B and trades at $16.92. The 52-week range is 3.11-17.49.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.1, Earnings Per Share (EPS) of $-1.53.
The stock has a beta of -0.21, operates in the Healthcare sector.
